210 related articles for article (PubMed ID: 24349352)
1. NFBD1/MDC1 is phosphorylated by PLK1 and controls G2/M transition through the regulation of a TOPOIIα-mediated decatenation checkpoint.
Ando K; Ozaki T; Hirota T; Nakagawara A
PLoS One; 2013; 8(12):e82744. PubMed ID: 24349352
[TBL] [Abstract][Full Text] [Related]
2. NFBD1/MDC1 participates in the regulation of G2/M transition in mammalian cells.
Bu Y; Suenaga Y; Okoshi R; Sang M; Kubo N; Song F; Nakagawara A; Ozaki T
Biochem Biophys Res Commun; 2010 Jun; 397(2):157-62. PubMed ID: 20529673
[TBL] [Abstract][Full Text] [Related]
3. Plk1-dependent phosphorylation regulates functions of DNA topoisomerase IIalpha in cell cycle progression.
Li H; Wang Y; Liu X
J Biol Chem; 2008 Mar; 283(10):6209-21. PubMed ID: 18171681
[TBL] [Abstract][Full Text] [Related]
4. NFBD1, like 53BP1, is an early and redundant transducer mediating Chk2 phosphorylation in response to DNA damage.
Peng A; Chen PL
J Biol Chem; 2003 Mar; 278(11):8873-6. PubMed ID: 12551934
[TBL] [Abstract][Full Text] [Related]
5. Genistein-induced neuronal apoptosis and G2/M cell cycle arrest is associated with MDC1 up-regulation and PLK1 down-regulation.
Ismail IA; Kang KS; Lee HA; Kim JW; Sohn YK
Eur J Pharmacol; 2007 Dec; 575(1-3):12-20. PubMed ID: 17706963
[TBL] [Abstract][Full Text] [Related]
6. Polo-like kinase 1 activated by the hepatitis B virus X protein attenuates both the DNA damage checkpoint and DNA repair resulting in partial polyploidy.
Studach L; Wang WH; Weber G; Tang J; Hullinger RL; Malbrue R; Liu X; Andrisani O
J Biol Chem; 2010 Sep; 285(39):30282-93. PubMed ID: 20624918
[TBL] [Abstract][Full Text] [Related]
7. Revised genetic requirements for the decatenation G2 checkpoint: the role of ATM.
Bower JJ; Zhou Y; Zhou T; Simpson DA; Arlander SJ; Paules RS; Cordeiro-Stone M; Kaufmann WK
Cell Cycle; 2010 Apr; 9(8):1617-28. PubMed ID: 20372057
[TBL] [Abstract][Full Text] [Related]
8. Geminin overexpression prevents the completion of topoisomerase IIα chromosome decatenation, leading to aneuploidy in human mammary epithelial cells.
Gardner L; Malik R; Shimizu Y; Mullins N; ElShamy WM
Breast Cancer Res; 2011 May; 13(3):R53. PubMed ID: 21595939
[TBL] [Abstract][Full Text] [Related]
9. Topoisomerase IIalpha controls the decatenation checkpoint.
Luo K; Yuan J; Chen J; Lou Z
Nat Cell Biol; 2009 Feb; 11(2):204-10. PubMed ID: 19098900
[TBL] [Abstract][Full Text] [Related]
10. NFBD1/MDC1 regulates Cav1 and Cav2 independently of DNA damage and p53.
Wilson KA; Colavito SA; Schulz V; Wakefield PH; Sessa W; Tuck D; Stern DF
Mol Cancer Res; 2011 Jun; 9(6):766-81. PubMed ID: 21551225
[TBL] [Abstract][Full Text] [Related]
11. Plk3 phosphorylates topoisomerase IIalpha at Thr(1342), a site that is not recognized by Plk1.
Iida M; Matsuda M; Komatani H
Biochem J; 2008 Apr; 411(1):27-32. PubMed ID: 18062778
[TBL] [Abstract][Full Text] [Related]
12. ATR enforces the topoisomerase II-dependent G2 checkpoint through inhibition of Plk1 kinase.
Deming PB; Flores KG; Downes CS; Paules RS; Kaufmann WK
J Biol Chem; 2002 Sep; 277(39):36832-8. PubMed ID: 12147700
[TBL] [Abstract][Full Text] [Related]
13. Phosphorylation of Plk1 at S137 and T210 is inhibited in response to DNA damage.
Tsvetkov L; Stern DF
Cell Cycle; 2005 Jan; 4(1):166-71. PubMed ID: 15611664
[TBL] [Abstract][Full Text] [Related]
14. MDC1 is a mediator of the mammalian DNA damage checkpoint.
Stewart GS; Wang B; Bignell CR; Taylor AM; Elledge SJ
Nature; 2003 Feb; 421(6926):961-6. PubMed ID: 12607005
[TBL] [Abstract][Full Text] [Related]
15. PLK1 targets NOTCH1 during DNA damage and mitotic progression.
De Blasio C; Zonfrilli A; Franchitto M; Mariano G; Cialfi S; Verma N; Checquolo S; Bellavia D; Palermo R; Benelli D; Screpanti I; Talora C
J Biol Chem; 2019 Nov; 294(47):17941-17950. PubMed ID: 31597699
[TBL] [Abstract][Full Text] [Related]
16. Mitotic entry upon Topo II catalytic inhibition is controlled by Chk1 and Plk1.
Arroyo M; Cañuelo A; Calahorra J; Hastert FD; Sánchez A; Clarke DJ; Marchal JA
FEBS J; 2020 Nov; 287(22):4933-4951. PubMed ID: 32144855
[TBL] [Abstract][Full Text] [Related]
17. NFBD1, a novel nuclear protein with signature motifs of FHA and BRCT, and an internal 41-amino acid repeat sequence, is an early participant in DNA damage response.
Shang YL; Bodero AJ; Chen PL
J Biol Chem; 2003 Feb; 278(8):6323-9. PubMed ID: 12475977
[TBL] [Abstract][Full Text] [Related]
18. A mitotic phosphorylation feedback network connects Cdk1, Plk1, 53BP1, and Chk2 to inactivate the G(2)/M DNA damage checkpoint.
van Vugt MA; Gardino AK; Linding R; Ostheimer GJ; Reinhardt HC; Ong SE; Tan CS; Miao H; Keezer SM; Li J; Pawson T; Lewis TA; Carr SA; Smerdon SJ; Brummelkamp TR; Yaffe MB
PLoS Biol; 2010 Jan; 8(1):e1000287. PubMed ID: 20126263
[TBL] [Abstract][Full Text] [Related]
19. NFBD1/MDC1, 53BP1 and BRCA1 have both redundant and unique roles in the ATM pathway.
Wilson KA; Stern DF
Cell Cycle; 2008 Nov; 7(22):3584-94. PubMed ID: 19001859
[TBL] [Abstract][Full Text] [Related]
20. 53BP1 and NFBD1/MDC1-Nbs1 function in parallel interacting pathways activating ataxia-telangiectasia mutated (ATM) in response to DNA damage.
Mochan TA; Venere M; DiTullio RA; Halazonetis TD
Cancer Res; 2003 Dec; 63(24):8586-91. PubMed ID: 14695167
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
